Gene amplification as a prognostic factor in primary brain tumors

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 215-222

  Olson, Jeffrey J ^a   Barnett, David ^a,c   Yang, Jin ^a,d   Assietti, Roberto ^a,c   Cotsonis, George ^b   James, C David ^a,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Baylor Medical Plaza ^*  (Italy)

^d EMORY UNIVERSITY HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURVIVAL; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; GENE AMPLIFICATION; GENE DOSAGE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE;

ADULT; AGED; BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GENE AMPLIFICATION; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE;

EID: 0031881733     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hynes, N. E. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development as a prognostic factor, and potential target for cancer therapy. Cancer Biol., 4: 19-26, 1993.
2. Bishop, J. M. The molecular genetics of cancers. Science (Washington DC), 235: 305-311, 1987.
3. Harris, C. C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51 (Suppl.): 5023s-5044s, 1991.
4. Weinberg, R. Tumor suppressor genes. Science (Washington DC), 254: 1138-1145, 1991.
5. James, C. D., and Olson, J. J. Molecular genetics and molecular biology advances in brain tumors. Curr. Opin. Oncol., 8: 188-195, 1996.
6. Spandidos, D. A., Liloglou, T., and Field, J. K. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy. Stem Cells, 11: 194-198, 1993.
7. Chang, F., Syrjanen, S., and Syrjanen, K. Implications of the p53 tumor-suppressor gene in clinical oncology. J. Clin. Oncol., 13: 1009-1022, 1995.
8. Gusterson, B. A. Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression. Eur. J. Cancer, 28: 263-267, 1992.
9. Duffy, M. J. Cellular oncogenes and suppressor genes as prognostic markers in cancer. Clin. Biochem., 26: 439-447, 1993.
10. Seeger, R. C., Brodeur, G. M., Sather, Dalton, A., Siegel, Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
11. Stark, G. R., and Giulotto, E. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell, 57: 901-908, 1989.
12. Salcman, M. Surgery for malignant gliomas. In: R. A. Morantz and J. W. Walsh (eds.), Brain Tumors: A Comprehensive Text, pp. 417-428. New York: Marcel Dekker, Inc., 1994.
13. Liberman, T. A., Nusbaum, H. R., and Razon, N. Amplification enhanced expression and possible rearrangement of the EGF receptor gene in primary brain tumors of glial origin. Nature (Lond.), 313: 144-147, 1985.
14. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA, 84: 6899-6903, 1987.
15. Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Petterson, R. F., and Collins, V. P. Genes for the epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res., 51: 2164-2172, 1991.
16. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736-2739, 1993.
17. Hunter, S. B., Abbott, M. S., Varma, V. A., Olson, J. J., Barnett, D. W., and James, C. S. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J. Neuropathol. Exp. Neurol., 54: 57-64, 1995.
18. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
19. Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P. S., and Collins, V. P. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicon shows preferential involvement of CDK4, SAS, MDM2. Cancer Res., 54: 4299-4303, 1994.
20. ink4 or pRb, or amplification associated with overexpression of CDK4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 21: 4833-4836, 1995.
21. Karnofsky, D. A., and Burchenal, J. H. The clinical evaluation of chemotherapeutic agents. In: C. M. MacLeod (ed.). Evaluation of Chemotherapeutic Agents,pp. 191-205. New York: Columbia Press, 1949.
22. James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48: 5546-5551, 1988.
23. Xu, Y. H., Ishii, S., Clark, A. J., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B, A., Merlino, G. T., and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
24. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., Georger, D. L., and Vogelstein, B. Amplification of a gene encoding p53-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
25. Khatib, Z. A., Matsushime, M. V., Valentine, M., Shapiro, D. N., Sherr, C. J., and Look, A. T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53: 5535-5541, 1993.
26. Hunter, S. B., Abbott, K., Varma, V. A., Olson, J. J., Barnett, D. W., and James, C. D. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J. Neuropathol. Exp. Neurol., 54: 57-64, 1995.
27. Olson, J. J., James, C. D., Krisht, A., Barnett, D., and Hunter, S. Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors. Neurosurgery, 36: 740-748, 1995.
28. Vertosick, F. T., Jr., and Selker, R. G. Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg. Neurol., 38: 359-363, 1992.
29. Chandler, K. L., Prados, M. D., Malec, M., and Wilson, C. B. Long term survival in patients with glioblastoma multiforme. Neurosurgery, 32: 716-720, 1993.
30. Pillai, R. Oncogenes and oncoproteins as tumor markers. Eur. J. Surg. Oncol., 18: 417-424, 1992.
31. Barrios, C., Castresana, J. S., Falkmer, U. G., Rosendahl, I., and Kreicbergs, A. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms. Int. J. Cancer, 58: 781-786, 1994.
32. Slamon, D. J., Clark, M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of HR-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
33. Varley, J. M., Swallow, J. E., Brammar, W. J., Whittaker, J. L., and Walker, R. Alterations in either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene, 1: 423-430, 1987.
34. van de Vijer, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J., and Nusse, R. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol., 7: 2019-2023, 1987.
35. Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B., and Hynes, N. E. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48: 1238-1243, 1988.
36. Guerin, M., Barrios, M., Perrier, M-J., Spielman, M., and Riou, G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogene in human breast carcinomas: correlation with poor prognosis. Oncogene, 3: 21-31, 1988.
37. Tandon, A. K., Clark, G. M., Chamness, C., Ullrich, A., and McGuire, W. L. Her-2/neu oncogene protein and prognosis in breast cancer. Clin. Oncol., 7: 1120-1128, 1989.
38. Tsuda, H., Hirohashi, S., Shimosata, Y., Hirota, T., Tsaugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., and Yodota, J. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB2/ear-1. Cancer Res., 49: 3104-3108, 1989.
39. Paik, S., Hazan, R., Fisher, E. R., Sass, R. E., Redmond, C., Schlessinger, J., Lippman, M. E., and King, C. R. Pathologic findings from the national surgical adjuvant breast and bowel project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J. Clin. Oncol., 8: 103-112, 1990.
40. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
41. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J. T., Dodge, R., Clark-Pearson, D. L., Marks, P., McKenzie, S., Yin, S., and Bast, R. C. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50: 4087-4091, 1990.
42. Zheng, J., Robinson, W. R., Ehlen, T., Yu, M. C., and Dubeau, L. Distinction of low grade from high grade ovarian carcinomas on the basis of loss of heterozygosity on chromosomes 3, 6 and 11 and HER-2/neu gene amplification. Cancer Res., 51: 4045-4051, 1991.
43. Shi, D., He, G., Cao, S., Pan, W., Zhang, H-Z., Yu, D., and Hung, M-C. Overexpression of the c-erb-B2/neu-encoded p185 protein in primary lung cancer. Mol. Carcinog., 5: 213-218, 1992.
44. Yonemura, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Tanaka, M., and Sasaki, T. Evaluation of immunoreactivity for erbB-2 protein as a marker for poor short term prognosis in gastric cancer. Cancer Res., 51: 1034-1038, 1991.
45. Schlegel, J., Merdes, A., Stumm, G., Albert, F. K., Forsting, M., Hynes, N., and Kiessling, M. Amplification of epidermal-growth-factor-receptor gene correlates with different growth behavior in human glioblastoma. Int. J. Cancer, 56: 72-77, 1994.
46. Burger, P. C., and Green, S. B. Patients age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer (Phila.), 59: 1617-1625, 1987.
47. Hurtt, M. R., Moossy, J., Donovan-Peluso, M., and Locker, J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J. Neuropathol. Exp. Neurol., 51: 84-90, 1992.
48. Bigner, S. H., Burger, P. C., Wong, A. J., Werner, M. H., Hamilton, S. R., Muhlbaier, L. H., Vogelstein, B., and Bigner, D. D. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J. Neuropathol. Exp. Neurol., 47: 191-205, 1988.
49. Torp, S. H., Helseth, E., Dalen, A., and Unsgaard, G. Relationships between Ki-67 labeling index, amplification of epidermal growth factor receptor gene, and prognosis in human glioblastoma. Acta Neurochir., 117: 182-186, 1992.
50. Kernohan, J. S., and Sayre, G. P. Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Washington, 1952.
51. Leenstra, S., Bijlsma, E. K., Troost, D., Oosting, J., Westerveld, A., Bosch, D. A., and Hulsebos, T. J. M. Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br. J. Cancer, 70: 684-689, 1994.
52. Waha, A., Baumann, A., Wolf, H. K., Fimmers, R., Neumann, J., Kindermann, D., Astrahantseff, K., Blumcke, I., Von Deimling, A., and Schlegel, U. Lack of prognostic relevance of alterations in the epidermal growth factor-transforming growth factor-α pathway in human astrocytic gliomas. J. Neurosurg., 85: 634-641, 1996.
53. Collins, V. P. Gene amplification in human gliomas. Glia, 15: 289-296, 1995.
54. ink4 homozygous deletions and CDK4 amplifications. J. Neurosurg., 84: 1020-1023, 1996.